about
GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System FunctionGDNF is not required for catecholaminergic neuron survival in vivoIncreased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout miceMice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.Characterization of the structural and functional determinants of MANF/CDNF in Drosophila in vivo modelA Simple Method for Improving the Spatial Resolution in Infrared Laser Ablation Mass Spectrometry Imaging.Permeation of Dopamine Sulfate through the Blood-Brain Barrier.AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF.Dicer and microRNAs protect adult dopamine neurons.Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra.Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice.Evidence for a link between tail biting and central monoamine metabolism in pigs (Sus scrofa domestica).High firing rate of neonatal hippocampal interneurons is caused by attenuation of afterhyperpolarizing potassium currents by tonically active kainate receptors.Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.Determination of steroids and their intact glucuronide conjugates in mouse brain by capillary liquid chromatography-tandem mass spectrometry.Analysis of intact glucuronides and sulfates of serotonin, dopamine, and their phase I metabolites in rat brain microdialysates by liquid chromatography-tandem mass spectrometry.Discovery of neurosteroid glucuronides in mouse brain.Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.Differences in basal and morphine-induced FosB/DeltaFosB and pCREB immunoreactivities in dopaminergic brain regions of alcohol-preferring AA and alcohol-avoiding ANA rats.Comparison of different amino acid derivatives and analysis of rat brain microdialysates by liquid chromatography tandem mass spectrometry.Analysis of acetylcholine and choline in microdialysis samples by liquid chromatography/tandem mass spectrometry.Dopaminergic modulation of reward-guided decision making in alcohol-preferring AA rats.Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats.Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice.Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.Mesolimbic dopamine release is linked to symptom severity in pathological gambling.The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum.Amphetamine primes enhanced motivation toward uncertain choices in rats with genetic alcohol preference.Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.Combination of CDNF and deep brain stimulation decreases neurological deficits in late-stage model Parkinson's disease.Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.Towards developing a model to study alcohol drinking and craving in female mice housed in automated cages.The effect of lipopolysaccharide (LPS) on inflammatory markers in blood and brain and on behavior in individually-housed pigs
P50
Q27309907-2F451FEA-E9D8-42B6-8E54-ED5E26923075Q27312615-E177FC94-6960-4325-9F9D-B103A587F59FQ28291496-189161CB-11B6-4725-B244-BEE9CE70F8EFQ30438217-B7F375AA-6221-49D5-B25D-AA8B62FB5637Q31137713-77369F6F-87E7-4F81-B29F-F6D6A68E4D5BQ33469609-C9338051-1F1F-454F-B0B7-9C720CC08A62Q35710747-BE9A0B2B-E481-4A27-89E7-24B94FEC8EB0Q36377899-7E5D9B03-8045-46A4-8CE5-1649215AA335Q38720888-EE507BDE-8D4F-4E09-808F-887290DA6F55Q38765041-85B02B80-8E16-4612-945E-ACC14177D498Q39460847-2F350834-4536-43C5-844C-827506ADA683Q39797272-CECA3D0B-3361-4DB9-B658-C102BD47E3EDQ40016812-BE6FE85A-009E-4C1A-9D6D-1CD7C2200DCEQ40137988-FBAE375F-D22D-4A8F-BD37-5D1A599F973BQ40249567-509641E2-DD80-44C5-B7D5-1AB29512DC99Q41330576-BF8EBF0F-349F-4129-92C6-9EA1A0180E50Q42170582-86A2E216-5A3E-4216-85C2-1CD1D7888086Q42187494-AEAD3AA6-51CD-4DF5-9F5B-74196739CDD4Q42441542-23CB25AF-FA0E-4A87-8F11-FB6AEB1B31CAQ43117596-0661C11C-7CEA-4958-8D17-F95580C3DBB0Q43273123-39678268-BB6B-42ED-BD01-64B4BDFE2F9DQ43280361-C06993B5-BFA0-4F21-8EAF-CD07A167E28DQ44339284-CD861735-85E7-4224-B641-CF926F47A949Q46073237-8A614746-3252-4458-9E24-8544184726BDQ46149552-1D684886-2267-4636-8E06-1B353D3511DBQ46717351-58EDE2A9-1054-4182-B0C0-1C7DB11B4844Q47358704-55A016C9-E752-4A15-BFCB-47BA030749EFQ47852599-9C6E70F1-4175-4391-8A75-84BA6001682DQ48111704-784313FB-0E70-49AC-A58A-5B31A2AD50C2Q48266494-26AF3D60-086E-4A42-B772-D573D54B2C74Q48469508-0B049860-7891-4E37-B680-0A2DD50A9FBAQ48652266-6DD26344-362D-4A52-9B11-30F33CBE7A15Q48735360-B2B03128-4303-404B-94B7-346E462693ECQ50050299-809621C3-DC3B-4CB3-8DD1-A965E8C6AD79Q50069089-66BFA15C-A832-4049-B2C3-C931B75F9A07Q50167197-D0C4B16A-40EC-40BF-8B9F-494813EA6556Q50952384-7310BC9E-AF9B-4626-AE08-BF97BAD0C1B9Q51267918-E3378E3D-9C45-4ACB-9EF5-25913D880E5CQ52639610-FCCE6793-FA0E-403A-BDB6-E0319C387CFEQ57465572-A7E42502-15D0-4308-AB2B-C372F3A66979
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Petteri Piepponen
@ast
Petteri Piepponen
@en
Petteri Piepponen
@es
Petteri Piepponen
@nl
Petteri Piepponen
@sl
type
label
Petteri Piepponen
@ast
Petteri Piepponen
@en
Petteri Piepponen
@es
Petteri Piepponen
@nl
Petteri Piepponen
@sl
altLabel
Timo Petteri Piepponen
@en
prefLabel
Petteri Piepponen
@ast
Petteri Piepponen
@en
Petteri Piepponen
@es
Petteri Piepponen
@nl
Petteri Piepponen
@sl
P106
P31
P496
0000-0002-2318-1612